These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 552098)

  • 1. Urinary prostaglandins in kidney disease.
    Papanicolaou N; Mountokalakis T; Palassides A; Paris M; Bariety J; Papavassiliou J; Merikas G; Milliez P
    Prostaglandins Med; 1979 Jul; 3(1):47-51. PubMed ID: 552098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Semeiological value of the electrophoretic analysis of urinary proteins].
    Traeger J; Manuel Y; Revillard JP; Friès D
    Bull Mem Soc Med Hop Paris; 1967 Feb; 118(3):203-15. PubMed ID: 6058836
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary excretion and renal production of prostaglandins E2, F2 alpha, and thromboxane B2 in experimental diabetes mellitus.
    Bunke M; Itskovitz H
    J Lab Clin Med; 1986 Oct; 108(4):332-9. PubMed ID: 3093617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is low urinary prostaglandin concentration a stage in the development of essential hypertension?
    Papanicolaou N; Safar M; Tsapara-Stavroulaki A; Baskiotis C; Lefkos N; Paris M; Marketos S; Bariéty J; Dontas A; Milliez P
    Prostaglandins Med; 1979 Jul; 3(1):53-67. PubMed ID: 399528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinalysis in patients on chronic hemodialysis.
    Cabaluna CC; Gary NE; Eisinger RP
    Urology; 1977 Aug; 10(2):103-4. PubMed ID: 898446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease.
    Sherman RL; Drayer DE; Leyland-Jones BR; Reidenberg MM
    Arch Intern Med; 1983 Jun; 143(6):1183-5. PubMed ID: 6190447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of prostaglandins (PGE2 and PGF2 alpha) and kallikrein in acute glomerulonephritis.
    Colina-Chourio JA; Rodríguez-Iturbe B; Baggio B; García R; Borsatti A
    Clin Nephrol; 1983 Nov; 20(5):217-24. PubMed ID: 6580982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary prostaglandin E2 excretion in chronic renal disease.
    Suzuki S; Shapiro R; Mulrow PJ; Tan SY
    Prostaglandins Med; 1980 May; 4(5):377-82. PubMed ID: 7403335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exaggerated fractional sodium excretion in hypertension with advanced renal disease: the role of renal prostaglandin and kallikrein.
    Abe K; Imai Y; Sato M; Haruyama T; Sato K; Hiwatari M; Kasai Y; Itoh S; Yasujima M; Seino M; Yoshinaga K
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():327s-330s. PubMed ID: 6914940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in prostaglandin excretion in chronic pyelonephritis in children].
    Ebela II
    Pediatriia; 1986 Feb; (2):22-4. PubMed ID: 3457355
    [No Abstract]   [Full Text] [Related]  

  • 11. [Elimination of the antibiotic cephacetril in patients with impaired renal function].
    Spring P; Räber J; Reber H; Dettli L
    Schweiz Med Wochenschr; 1973 May; 103(21):783-8. PubMed ID: 4704362
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase, alanine aminopeptidase and lysozyme in patients with renal disease.
    Palmieri L; Ronca G; Cioni L; Puccini R
    Contrib Nephrol; 1984; 42():123-9. PubMed ID: 6152415
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renal chloramphenicol clearance in patients with chronic pyelonephritis, glomerulonephritis or polycystic kidneys (author's transl)].
    Schück O; Prát V; Grafnetterová J; Kotanová E
    Cas Lek Cesk; 1975 Apr; 114(14):424-7. PubMed ID: 1139594
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prostaglandin E2 and F2 excretion in children with glomerulonephritis].
    Januszewicz P; Wyszyńska T; Ignanowska-Switalska H
    Pediatr Pol; 1983 Mar; 58(3):243-8. PubMed ID: 6578492
    [No Abstract]   [Full Text] [Related]  

  • 15. [Excretion of group substances ABO (H) with the urine in various kidney diseases].
    Kalinowski M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):144-63. PubMed ID: 4128512
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinalysis and clinical renal disease.
    Szwed JJ
    Am J Med Technol; 1980 Oct; 46(10):720-5. PubMed ID: 7211937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between urinary prostaglandin (PGE2 and PGF2 alpha) and sodium excretion in various stages of chronic liver disease.
    Wernze H; Müller G; Goerig M
    Adv Prostaglandin Thromboxane Res; 1980; 7():1089-96. PubMed ID: 7369021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FIBRINOLYTIC ACTIVITY IN PLASMA AND URINE IN CHRONIC RENAL DISEASE.
    EDWARD N; YOUNG DP; MACLEOD M
    J Clin Pathol; 1964 May; 17(3):365-8. PubMed ID: 14159486
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary prostaglandins E2 and F2 alpha in chronic renal failure. Influence of chronic and acute changes in Na balance.
    Schneider M; Rathaus M; Shapira J; Bernheim J
    Nephron; 1985; 40(2):152-4. PubMed ID: 3858702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased renal excretion of 3 hydroxyproline in patients with active glomerular nephropathies and with polycystic renal disease.
    Chanard J; Szymanowicz A; Brunois JP; Toupance O; Melin JP; Birembaut P; Randoux A; Borel PJ
    Clin Nephrol; 1982 Feb; 17(2):64-9. PubMed ID: 7067168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.